05 Aug 2024 --- Many US trade associations representing the supplement industry oppose the recently proposed Dietary Supplement Listing Act of 2024, with reactions ranging from “misguided,” “unnecessary” and “burdensome” to the proposal being “too limited.” The bill, proposed by US Senator Richard Durbin, would introduce mandatory supplement listing in a US Food & Drug Administration (FDA) database. We examine the industry’s feedback and suggestions for alternative and additional reforms. Although the Council for Science in the Public Interest (CSPI) says the legislation is a “step in the right direction,” the organization calls for much broader reforms.
